Mindestbestellung 120 EUR Kostenlose Lieferung ab 250 EUR Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 250 EUR Aktionen

Substanzen · Lysergamide

ETH-LAD

C21H27N3O CAS 65527-61-9 Nur für analytische Forschungszwecke — nicht für den menschlichen Verzehr
Bevorzugter Name
ETH-LAD
IUPAC-Name
(6aR,9R)-N,N,7-triethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
CAS-Nummer der Stammverbindung (Referenz)
65527-61-9
Summenformel
C21H27N3O
Molekulargewicht
337.5 g/mol
InChIKey
MYNOUXJLOHVSMQ-DNVCBOLYSA-N
PubChem
CID 44457783
Quelle
PubChem
Geprüfte Synonyme und Katalogkürzel
6-Ethyl-6-nor-LSD ETHLAD ETH LAD

Passende Artikel im aktuellen Shop-Katalog

Geprüftes Pharmakologie- & Toxikologie-Dossier

ETH-LAD

Potent N6-Ethyl Lysergamide (5-HT2A Partial Agonist) Lysergamide
Geprüfte PubChem- & CAS-Identität C21H27N3O · CAS 65527-61-9 · CID 44457783
Kalibrierte Lieferform Gelöste Flüssigkeitslösung (µg-kalibriert)
≥98 % analytische Reinheit geprüft 337.5 g/mol
WHO-, PubMed- & PubChem-Quellen 2 cited records

Rezeptor-Telemetrie & Wirkmechanismus

5-HT₂ₐ Perceptual & Visual Signaling Partial Agonist
5-HT₁ₐ / 5-HT₂c Serotonergic Modulation Active
D₂ / Adrenergic Dopaminergic / Somatic Tone Moderate

Direct N6-ethyl-nor-LSD agonist showing slightly higher in vitro 5-HT2A affinity than LSD-25 itself.

Biotransformation & Active Metabolites

Directly active without conversion to LSD-25.

Zeitliche Pharmakokinetik

Potent N6-Ethyl Lysergamide (5-HT2A Partial Agonist) — Supplied as dissolved liquid solution; ~20–30% steeper per microgram than 1P-LSD/1cP-LSD with pronounced visual density and early somatic thermoregulation/nausea sensitivity above 120 ug.

  1. Onset 30–75 min
  2. Peak Window 2–4 h
  3. Total Window 8–12 h
  4. Residual / Half-Life 4–8 h residual

Supplied as dissolved liquid solution; ~20–30% steeper per microgram than 1P-LSD/1cP-LSD with pronounced visual density and early somatic thermoregulation/nausea sensitivity above 120 ug.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
15–20 ug
Cognitive & Sensory

Subtle threshold receptor activity (Potent N6-Ethyl Lysergamide (5-HT2A Partial Agonist)).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
20–60 ug
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
60–120 ug
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
120–200 ug
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
200+ ug
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

Lithium salts

Strongly documented to provoke acute tonic-clonic seizures, fugue states, and severe psychotic episodes with lysergamides.

Tramadol

Lowers seizure threshold alongside 5-HT2A excitation.

Hohes Risiko — Vermeiden

Cannabis & Strong Stimulants (Cathinones, Amphetamines, Cocaine)

Exponentially amplifies thought loops, tachycardia, anxiety, and acute paranoia.

Vorsicht / Abschwächung

SSRIs / SNRIs & Benzodiazepines

Chronic SSRIs and acute benzodiazepines markedly attenuate 5-HT2A perceptual effects.

Isomeren- & Strukturvergleich

Supplied as dissolved liquid solution; ~20–30% steeper per microgram than 1P-LSD/1cP-LSD with pronounced visual density and early somatic thermoregulation/nausea sensitivity above 120 ug.

Stabilität & Lagerung

Form: Clear, colorless calibrated liquid solution for microgram (µg) volumetric measurement. · Supplied pre-dissolved in analytical carrier; sensitive to chlorine/tap water.

Highly sensitive to UV light, heat, and chlorine; store airtight in amber glass under cold/refrigerated conditions.

Cross-Tolerance & Dependence Profile

Immediate rapid 5-HT2A receptor downregulation within hours, cross-tolerant with all tryptamines and phenethylamines; baseline sensitivity typically resets over 10–14 days. Non-addictive physiologically.

Analytische & toxikologische Monographie

ETH-LAD ((6aR,9R)-N,N,7-triethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide; CAS 65527-61-9, PubChem CID 44457783) is a lysergamide reference compound (C21H27N3O, 337.5 g/mol) classified pharmacologically as a Potent N6-Ethyl Lysergamide (5-HT2A Partial Agonist). Direct N6-ethyl-nor-LSD agonist showing slightly higher in vitro 5-HT2A affinity than LSD-25 itself. Directly active without conversion to LSD-25. In published observational and toxicological literature, threshold response is noted at 15–20 ug, light range at 20–60 ug, common reference range at 60–120 ug, strong intensity at 120–200 ug, and heavy/adverse territory at 200+ ug, with an onset of 30–75 min, peak window of 2–4 h, and total duration of 8–12 h (4–8 h residual). Supplied as dissolved liquid solution; ~20–30% steeper per microgram than 1P-LSD/1cP-LSD with pronounced visual density and early somatic thermoregulation/nausea sensitivity above 120 ug. Critical contraindications include Lithium salts, Tramadol.

Chemische Struktur und Molekülprofil

ETH-LAD ((6aR,9R)-N,N,7-triethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide) ist eine Referenzverbindung aus der Stoffklasse Lysergamide mit der Summenformel C21H27N3O und einer molaren Masse von 337.5 g/mol. Die Stammverbindung wird unter der CAS-Nummer 65527-61-9 sowie in der NCBI-PubChem-Datenbank unter CID 44457783 geführt (Standard-InChIKey: MYNOUXJLOHVSMQ-DNVCBOLYSA-N).

Quellen

Referenztoxikologie und Sicherheitsprofil

Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört ETH-LAD zur chemischen Klasse Lysergamides. Toxikologische Hinweise (PsychonautWiki): die genaue toxische Schwelle ist nicht festgelegt. Abhängigkeitspotenzial (PsychonautWiki): nicht gewohnheitsbildend. Dokumentierte Kreuztoleranz: psychedelic. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.

Quellen

Analytischer Verwendungszweck und Laborhinweis

Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.

Quellen

Dokumentierte Wechselwirkungen und Kontraindikationen

Hohes Risiko / Gefährliche Kombinationen

Unsichere Kombinationen (erhöhtes Risiko)

Ungeklärte Wechselwirkungen (Vorsicht geboten)